Abbvie Inc (ABBV)

Jan 17, 2025, 7:30 AM EST - 15 hours ago

Income & Growth: 3 Of The Best Dividend Stocks For Any Market

KO TRP

Jan 15, 2025, 2:28 PM EST - 2 days ago

AbbVie Inc. (ABBV) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)

Jan 15, 2025, 12:10 PM EST - 2 days ago

AbbVie to 'commit less capital' towards psychiatric drugs, CEO says

Jan 15, 2025, 8:10 AM EST - 2 days ago

My Dividend Stock Portfolio: $10,000 In Dividends In 2024 - 97 Holdings With 13 Buys

AAPL AGNC AM APLE ARCC ARI AVGO

Jan 15, 2025, 8:00 AM EST - 2 days ago

Alzamend Neuro to Present at the Sequire Investor Summit

Jan 14, 2025, 5:08 AM EST - 3 days ago

AbbVie Has Immense Cash Flow Potential

Jan 13, 2025, 6:10 PM EST - 4 days ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

AMGN AZN BNTX FBCG GILD GSK IBB

Jan 13, 2025, 12:07 PM EST - 4 days ago

Drugmakers rush to sign deals on first day of industry conference

GSK ITCI JNJ LLY

Jan 13, 2025, 9:18 AM EST - 4 days ago

China's Simcere Pharma grants AbbVie option to license its blood cancer drug candidate

Jan 13, 2025, 9:05 AM EST - 4 days ago

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

Jan 13, 2025, 9:00 AM EST - 4 days ago

AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

Jan 13, 2025, 8:31 AM EST - 4 days ago

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

RGNX

Jan 11, 2025, 6:38 AM EST - 6 days ago

11 Upcoming Dividend Increases, Including A Dividend King

ALG EOG GGG HRL MAA NWFL OZK

Jan 10, 2025, 11:51 AM EST - 7 days ago

AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug

Jan 10, 2025, 9:30 AM EST - 7 days ago

MoneyShow's Best Investment Ideas For 2025: Part 2

AEM MS NMR SMCI

Jan 10, 2025, 8:44 AM EST - 7 days ago

Abbvie to record $3.5 bln charge related to schizophrenia drug

Jan 9, 2025, 9:35 AM EST - 8 days ago

AbbVie's Stock Is Unfairly Cheap

Jan 9, 2025, 8:00 AM EST - 8 days ago

AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 8:00 AM EST - 10 days ago

CoolMonth is Back With Deals on CoolSculpting® Elite by Allergan Aesthetics

Jan 6, 2025, 4:46 PM EST - 11 days ago

AbbVie cuts 2024 profit forecast on acquisition expenses

Jan 3, 2025, 8:00 AM EST - 14 days ago

AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call

Jan 3, 2025, 7:39 AM EST - 14 days ago

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

AMGN CVS

Dec 30, 2024, 7:30 AM EST - 18 days ago

Highest Quality Dividend Kings For 2025

ABT ADP CBSH CINF DOV GWW ITW

Dec 24, 2024, 7:00 AM EST - 24 days ago

Into 2025: Top 8 Stocks I Own And Why (Part II)

GOLD GOOG GOOGL JNK KGC NEM QUBT

Dec 19, 2024, 7:30 AM EST - 4 weeks ago

Retirement-Ready Income: 5 Dividend Gems I'd Buy If I Were 65

MPLX O TXN VICI

Dec 18, 2024, 8:10 AM EST - 4 weeks ago

My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys

AAPL AGNC AM APLE ARCC ARI AVGO

Dec 18, 2024, 8:00 AM EST - 4 weeks ago

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Dec 17, 2024, 8:19 AM EST - 4 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

BMY CVS

Dec 16, 2024, 3:28 PM EST - 4 weeks ago

AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors

Dec 16, 2024, 11:37 AM EST - 4 weeks ago

AbbVie Enters Oversold Territory

Dec 13, 2024, 11:54 PM EST - 4 weeks ago

Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value

AAPL ABT ACN ADBE ADP AMGN AMZN

Dec 13, 2024, 9:15 AM EST - 5 weeks ago

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

Dec 13, 2024, 4:41 AM EST - 5 weeks ago

Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends

ADM BKH CWT ED FTS HRL KMB

Dec 12, 2024, 8:00 AM EST - 5 weeks ago

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

Dec 11, 2024, 1:12 PM EST - 5 weeks ago

Betting Big On AbbVie: A Prescription For Growth And Dividends

Dec 11, 2024, 9:15 AM EST - 5 weeks ago

AbbVie Completes Acquisition of Aliada Therapeutics

Dec 10, 2024, 3:42 PM EST - 5 weeks ago

Buy 1 December Aristocrat Of 67 From 38 With 'Safer' Dividends

ADM ALB AMCR APD ATO BEN CHRW

Dec 10, 2024, 8:30 AM EST - 5 weeks ago

Dividend Income Summary: Lanny's November 2024 Summary

CAT CVS CZNC DE ETN GD HRL

Dec 9, 2024, 12:00 PM EST - 5 weeks ago

Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma

Dec 9, 2024, 10:52 AM EST - 5 weeks ago

AbbVie's third successful Parkinson's trial sets the stage for an eventful 2025

Dec 9, 2024, 9:04 AM EST - 5 weeks ago

Don't Miss The Dividend Train: 2 Top Buys To End 2024

CVX

Dec 9, 2024, 8:10 AM EST - 5 weeks ago

AbbVie's Parkinson's disease drug meets main goal in late-stage study

Dec 9, 2024, 8:00 AM EST - 5 weeks ago

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

Dec 8, 2024, 3:00 PM EST - 5 weeks ago

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients

Dec 7, 2024, 7:00 PM EST - 5 weeks ago

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Dec 5, 2024, 1:31 PM EST - 6 weeks ago

Calls of the Day: Toast, Abbvie, Berkshire Hathaway

TOST

Dec 3, 2024, 2:26 PM EST - 6 weeks ago

AbbVie Inc. (ABBV) Citi's 2024 Global Healthcare Conference (Transcript)

Dec 3, 2024, 7:39 AM EST - 6 weeks ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

BMY PDCO

Nov 29, 2024, 7:30 AM EST - 7 weeks ago

Forget Big Tech - I'll Take Dividend Stalwarts Any Day

AAPL AMZN AXP CVX GOOG GOOGL HD

Nov 26, 2024, 7:07 AM EST - 7 weeks ago

My Best Dividend Aristocrats For December 2024

ADM ADP ALB AMCR ATO BDX BEN